T1	HMM 529 537	efficacy
T2	HMM 778 841	Response, progression-free survival (PFS), and overall survival
T3	HMM 1050 1063	response rate
T4	HMM 1102 1153	disease-control rate (response plus stable disease)
T5	HMM 1167 1177	median PFS
T6	HMM 1374 1397	median overall survival
T7	HMM 1618 1634	clinical benefit
